Abstract
Atherosclerosis is one of the most common causes of death worldwide. Epidemiology studies firmly established an inverse relationship between atherogenesis and distorted lipid metabolism, in particular, higher levels of total cholesterol, an accumulation of CH-laden macrophages (foam cells), and lower plasma levels of antiatherogenic high density lipoprotein (HDL). It is believed that the reverse cholesterol transport, a process that removes excess cholesterol from peripheral tissues/cells including macrophages to circulating HDL, is one of the main mechanisms responsible for anti-atherogenic properties of HDL. The key proteins of reverse cholesterol transport—ATP-binding cassette transporters A1 (ABCA1) and G1 (ABCG1)—mediate the cholesterol efflux from macrophages and prevent their transformation into foam cells. This review focuses on the role of ABC transporters A1 and G1 in the pathogenesis of atherosclerosis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Feig J.E., Shamir R., Fisher E.A. 2008. Atheroprotective effects of HDL: Beyond reverse cholesterol transport. Curr. Drug. Targets. 9 (3), 196–203.
Oram J.F., Vaughan A.M. 2006. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ. Res. 99, 1031–1043.
Ono K. 2012. Current concept of reverse cholesterol transport and novel strategy for atheroprotection. J. Cardiol. 60 (5), 339–343.
Meurs I., Van Eck M., Van Berkel T.J. 2010. High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis. Curr. Pharm. Des. 16 (13), 1445–1467.
Chen W., Silver D.L., Smith J.D., Tall A.R. 2000. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages. J. Biol. Chem. 275 (40), 30794–30800.
Singaraja R.R., Fievet C., Castro G. James E.R., Hennuyer N., Clee S.M., Bissada N., Choy J.C., Fruchart J.C., McManus B.M., Staels B., Hayden M.R. 2002. Increased ABCA1 activity protects against atherosclerosis. J. Clin. Invest. 110 (1), 35–42.
Jessup W., Gelissen I.C., Gaus K., Kritharides L. 2006. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr. Opin. Lipidology. 17, 247–257.
Gelissen I.C., Harris M., Rye K.A., Quinn C., Brown A.J., Kockx M., Cartland S., Packianathan M., Kritharides L., Jessup W. 2006. ABCA1 and ABCG1 synergize to mediate cholesterol export to ApoA-I. Arterioscler. Thromb. Vasc. Biol. 26, 534–540.
Kontush A., Chapman M.J. 2006. Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacology. 58, 342–374.
Miller M., Rhyne J., Hamlette S., Birnbaum J., Rodriguez A. 2003. Genetics of HDL regulation in humans. Curr. Opin. Lipidol. 14, 273–279.
Hovingh G.K., de Groot E., van der Steeg W., Boekholdt S.M., Hutten B.A., Kuivenhoven J.A., Kastelein J.J. 2005. Inherited disorders of HDL metabolism and atherosclerosis. Curr. Opin. Lipidol. 16 (2), 139–145.
Schaefer J.R., Rader D.J., Ikewaki K., Fairwell T., Zech L.A., Kindt M.R., Davignon J., Gregg R.E., Brewer H.B. Jr. 1992. In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 12, 843–848.
Frenais R., Ouguerram K., Maugeais C. Marchini J.S., Benlian P., Bard J.M., Magot T., Krempf M. 1999. Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: A stable isotope study. J. Lipid Res. 40, 1506–1511.
Yokoyama S. 2006. ABCA1 and biogenesis of HDL. J. Atheroscler. Tromb. 13, 1–15.
Cuchel M., Rader D.J. 2006. Macrophage reverse cholesterol transport key to the regression of atherosclerosis. Circulation. 113, 2548–2555.
Shchelkunova T.A., Morozov I.A., Rubtsov P.M., Samokhodskaya L.M., Andrianova I.V., Sobenin I.A., Orekhov A.N., Smirnov A.N. 2013. Changes in levels of gene expression in human aortal intima during atherogenesis. Biochemistry (Moscow). 78 (5), 463–470.
Barry H., Cole S., Kuchler K., Higgins C.F. 2003. ABC Proteins: From Bacteria to Man. London: Academic.
Luciani M.F., Denizot F., Savary S., Mattei M.G., Chimini G. 1994. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics. 21, 150–159.
Voloshyna I., Reiss A.B. 2011. The ABC transporters in lipid flux and atherosclerosis. Prog. Lipid. Res. 50 (3), 213–224.
Klucken J., Buchler C., Orso E., Kaminski W.E., Porsch-Ozcürümez M., Liebisch G., Kapinsky M., Diederich W., Drobnik W., Dean M., Allikmets R., Schmitz G. 2000. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc. Natl. Acad. Sci. U. S. A. 97, 817–822.
Mauldin J.P., Nagelin M.H., Wojcik A.J. Srinivasan S., Skaflen M.D., Ayers C.R., McNamara C.A., Hedrick C.C. 2008. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation. 117, 2785–2792.
Dushkin M.I. 2006. Macrophages and atheroscletosis: Pathophysiological and therapeutic aspects. Byull. Sib. Otd. Ross. Akad. Med. Nauk. 26 (120), 47–55.
Rohatgi A., Khera A., Berry J.D., Givens E.G., Ayers C.R., Wedin K.E., Neeland I.J., Yuhanna I.S., Rader D.R., de Lemos J.A., Shaul P.W. 2014. HDL cholesterol efflux capacity and incident cardiovascular events. N. Engl. J. Med. 371 (25), 2383–2393.
Van Eck M., Bos I.S., Kaminski W.E., Orsó E., Rothe G., Twisk J., Böttcher A., Van Amersfoort E.S., Christiansen-Weber T.A., Fung-Leung W.P., Van Berkel T.J., Schmitz G. 2002. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc. Natl. Acad. Sci. U. S. A. 99 (9), 6298–6303.
Yvan-Charvet L., Ranalletta M., Wang N., Han S., Terasaka N., Li R., Welch C., Tall A.R. 2007. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117 (12), 3900–3908.
Kennedy M.A., Barrera G.C., Nakamura K., Baldán A., Tarr P., Fishbein M.C., Frank J., Francone O.L., Edwards P.A. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1, 121–131.
Engel T., Kannenberg F., Fobker M., Nofer J.R., Bode G., Lueken A., Assmann G., Seedorf U. 2007. Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7 beta-hydroxycholesterol. FEBS Lett. 581, 1673–1680.
Terasaka N., Wang N., Yvan-Charvet L., Tall A.R. 2007. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc. Natl. Acad. Sci. U. S. A. 104, 15093–15098.
Yvan-Charvet L., Welch C., Pagler T.A., Ranalletta M., Lamkanfi M., Han S., Ishibashi M., Li R., Wang N., Tall A.R. 2008. Increased Inflammatory gene expression in ABC transporter-deficient macrophages free cholesterol accumulation, increased signaling via Tolllike receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation. 118, 1837–1847.
Ma L., Dong F., Zaid M., Kumar A., Zha X. 2012. ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation. J. Biol. Chem. 287 (48), 40502–40512.
Terasaka N., Yu S., Yvan-Charvet L., Wang N., Mzhavia N., Langlois R., Pagler T., Li R., Welch C.L., Goldberg I.J., Tall A.R. 2008. ABCG1 and HDL protect against endothelial dysfunction in mice fed a highcholesterol diet. J. Clin. Invest. 118, 3701–3713.
Oram J.F., Heinecke J.W. 2005. ATP-binding cassette transporter A1: A cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 85 (4), 1343–1372.
Zhao C., Dahlman-Wright K. 2010. Liver X receptor in cholesterol metabolism. J. Endocrinol. 204 (3), 233–240.
Schmitz G, Buechler C. 2002. ABCA1: Regulation, trafficking and association with heteromeric proteins. Ann. Med. 34, 334–347.
Adlakha Y.K., Khanna S., Singh R., Singh V.P., Agrawal A., Saini N. 2013. Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRa expression and cholesterol homeostasis. Cell Death Dis. 4, e780.
Guay S.P., Brisson D., Munger J., Lamarche B., Gaudet D., Bouchard L. 2012. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics. 7 (5), 464–472.
Peng P., Wang L., Yang X., Huang X., Ba Y., Chen X., Guo J., Lian J., Zhou J. 2014. A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease. PLoS ONE. 9 (8), e102265.
Nazarenko M.S., Markov A.V., Lebedev I.N., Sleptsov A.A., Frolov A.V., Barbarash O.L., Barbarash L.S., Puzyrev V.P. 2013. DNA methylation profiling of the vascular tissues in the setting of atherosclerosis. Mol. Biol. (Moscow). 47 (3), 352–357.
Seo D., Wang T., Dressman H., Herderick E.E., Iversen E.S., Dong C., Vata K., Milano C.A., Rigat F., Pittman J., Nevins J.R., West M., Goldschmidt-Clermont P.J. 2004. Gene expression phenotypes of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 1922–1927.
Sinnaeve P.R., Donahue M.P., Grass P., Seo D., Vonderscher J., Chibout S.D., Kraus W.E., Sketch M., Jr., Nelson C., Ginsburg G.S., Goldschmidt-Clermont P.J., Granger C.B. 2009. Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PLoS ONE. 4 (9), e7037.
Korkor M.T., Meng G.B., Xing S.Y., Zhang M.C., Guo J.R., Zhu X.X., Yang P. 2011. Microarray analysis of differential gene expression profile in peripheral blood cells of patients with human essential hypertension. Int. J. Med. Sci. 8 (2), 168–179.
Sivapalaratnam S., Basart H., Watkins N.A., Maiwald S., Rendon A., Krishnan U., Sondermeijer B.M., Creemers E.E., Pinto-Sietsma S.J., Hovingh K., Ouwehand W.H., Kastelein J.J., Goodall A.H., Trip M.D. 2012. Monocyte gene expression signature of patients with early onset coronary artery disease. PLoS ONE. 7, e32166.
Di Gregoli K., Johnson J.L. 2012. Role of colony-stimulating factors in atherosclerosis. Curr. Opin. Lipidol. 23 (5), 412–421.
Waldo S.W., Li Y., Buono C., Billings E.M., Chang J., Kruth H.S. 2008. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am. J. Pathol. 172, 1112–1126.
Demina E.P., Miroshnikova V.V., Rodygina T.I., Kuriyanov P.S., Vinogradov A.G., Denisenko A.D., Schwarzman A.L. 2011. ABCA1 gene expression in peripheral blood lymphocytes and macrophages in patients with atherosclerosis. Mol. Biol. (Moscow). 45 (2), 258–262.
Demina E.P., Miroshnikova V.V., Maiorov N.V. Davydenko V.V., Schwarzman A.L. 2013. ABCA1 gene mRNA and ABCA1 protein level in M-CSF-activated macrophages of patients with arterial stenosis. Tsitologiya. 55 (8), 580–585.
Wong J., Quinn C.M., Gelissen I.C., Jessup W., Brown A.J. 2008. The effect of statins on ABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiation. Atherosclerosis. 196 (1), 180–189.
Genvigir F.D., Rodrigues A.C., Cerda A., Arazi S.S., Willrich M.A., Oliveira R., Hirata M.H., Dorea E.L., Bernik M.M., Curi R., Hirata R.D. 2010. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells. Pharmacogenomics. 11 (9), 1235–1246.
Albrecht C., Soumian S., Amey J.S., Sardini A., Higgins C.F., Davies A.H., Gibbs R.G. 2004. ABCA1 expression in carotid atherosclerotic plaques. Stroke. 35 (12), 2801–2806.
Liu H.F., Cui K.F., Wang J.P., Zhang M., Guo Y.P., Li X.Y., Jiang C. 2012. Significance of ABCA1 in human carotid atherosclerotic plaques. Exp. Ther. Med. 4 (2), 297–302.
Soumian S., Gibbs R., Davies A., Albrecht C. 2005. mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease. J. Clin. Pathol. 58 (12), 1255–1260.
Miroshnikova V.V., Demina E.P., Maiorov N.V., Davydenko V.V., Kuriyanov P.S., Vavilov V.N., Vinogradov A.G., Denisenko A.D., Schwarzman A.L. 2014. Specific features of ABCG1 transporter gene expression in peripheral plood mononuclar cells of patients with atherosclerosis. Tsitologiya. 56 (3), 234–240.
Wellington C.L., Walker E.K., Suarez A., Kwok A., Bissada N., Singaraja R., Yang Y.Z., Zhang L.H., James E., Wilson J.E., Francone O., McManus B.M., Hayden M.R. 2002. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab. Invest. 82 (3), 273–283.
Kang M.H., Singaraja R., Hayden M.R. 2010. Adenosine-triphosphate-binding cassette transporter-1 trafficking and function. Trends Cardiovasc. Med. 20 (2), 41–49.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.P. Demina, V.V. Miroshnikova, A.L. Schwarzman, 2016, published in Molekulyarnaya Biologiya, 2016, Vol. 50, No. 2, pp. 223–230.
Rights and permissions
About this article
Cite this article
Demina, E.P., Miroshnikova, V.V. & Schwarzman, A.L. Role of the ABC transporters A1 and G1, key reverse cholesterol transport proteins, in atherosclerosis. Mol Biol 50, 193–199 (2016). https://doi.org/10.1134/S0026893316020047
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893316020047